Maxim starts KindlyMD at Buy, sees meaningful scale from BTC Inc. deal

As previously reported, Maxim analyst Matthew Galinko initiated coverage of KindlyMD (NAKA) with a Buy rating and $8 price target The firm is positive on the company’s deep experience in the digital asset space and its Bitcoin treasury strategy, with plans to meaningfully increase holdings, the analyst tells investors in a research note. The pending acquisition of BTC Inc. should also add meaningful scale to KindlyMD’s operating businesses and provide a well-established media platform focused on digital assets, Maxim notes, adding that this asset generates cash flow and should enhance the company’s visibility among Bitcoin investors.